linear regression models Search Results


linear regression model  (RStudio)
90
RStudio linear regression model
Linear Regression Model, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/linear+regression+model/10__3390_slash_f13020151-101-2-12
Average 90 stars, based on 1 article reviews
linear regression model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear model  (Schmid GmbH)
90
Schmid GmbH linear model
Linear Model, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/linear+regression+model/10__1016_slash_j__gecco__2025__e03609-146-6-14
Average 90 stars, based on 1 article reviews
linear model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear model  (OriginLab corp)
90
OriginLab corp linear model
Linear Model, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/linear+regression+model/bio_rxiv__2025__07__16__665088-177-2-28
Average 90 stars, based on 1 article reviews
linear model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear regression model r version 6.3.1  (RStudio)
90
RStudio linear regression model r version 6.3.1
Linear Regression Model R Version 6.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/linear+regression+model+r+version+6+3+1/pm32235877-264-5-8
Average 90 stars, based on 1 article reviews
linear regression model r version 6.3.1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear regression model  (Meditron GmbH)
90
Meditron GmbH linear regression model
Linear Regression Model, supplied by Meditron GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/linear+regression+model/med_rxiv__2024__10__14__24315448-81-5-0
Average 90 stars, based on 1 article reviews
linear regression model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
log–log transformed linear model (regression analysis in rstudio 1.0.136)  (RStudio)
90
RStudio log–log transformed linear model (regression analysis in rstudio 1.0.136)
Log–Log Transformed Linear Model (Regression Analysis In Rstudio 1.0.136), supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/log+log+transformed+linear+model++regression+analysis+in+rstudio+1+0+136+/pmc06360077-106-20-27
Average 90 stars, based on 1 article reviews
log–log transformed linear model (regression analysis in rstudio 1.0.136) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear regression analysis xlstat  (Addinsoft inc)
90
Addinsoft inc linear regression analysis xlstat
Linear Regression Analysis Xlstat, supplied by Addinsoft inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/multiple+linear+regression+model/pm34663792-376-1-5
Average 90 stars, based on 1 article reviews
linear regression analysis xlstat - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
gp2 igg  (CH Instruments)
90
CH Instruments gp2 igg
Rate of <t> anti-GP2 </t> antibody positivity in the UC, CD, and control groups
Gp2 Igg, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/linear+regression+model/pmc06389294-144-37-92
Average 90 stars, based on 1 article reviews
gp2 igg - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
regression methods in biostatistics: linear, logistic, survival and repeated measures models  (Verlag GmbH)
90
Verlag GmbH regression methods in biostatistics: linear, logistic, survival and repeated measures models
Rate of <t> anti-GP2 </t> antibody positivity in the UC, CD, and control groups
Regression Methods In Biostatistics: Linear, Logistic, Survival And Repeated Measures Models, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/regression+modeling+strategies++with+applications+to+linear+models++logistic+and+ordinal+regression++and+survival+analysis/10__1212_slash_wnl__0b013e3182315a56-127-15-18
Average 90 stars, based on 1 article reviews
regression methods in biostatistics: linear, logistic, survival and repeated measures models - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
generalized linear regression model  (RStudio)
90
RStudio generalized linear regression model
Rate of <t> anti-GP2 </t> antibody positivity in the UC, CD, and control groups
Generalized Linear Regression Model, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/generalized+linear+regression+model/pmc08863217-89-14-17
Average 90 stars, based on 1 article reviews
generalized linear regression model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
generalized linear mixed model regression procedure incorporating a gamma distribution and logarithm-link function  (vsn international)
90
vsn international generalized linear mixed model regression procedure incorporating a gamma distribution and logarithm-link function
Rate of <t> anti-GP2 </t> antibody positivity in the UC, CD, and control groups
Generalized Linear Mixed Model Regression Procedure Incorporating A Gamma Distribution And Logarithm Link Function, supplied by vsn international, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/generalized+linear+mixed+model+regression+procedure+incorporating+a+gamma+distribution+and+logarithm+link+function/10__1203_slash_pdr__0b013e3182042a20-65-25-29
Average 90 stars, based on 1 article reviews
generalized linear mixed model regression procedure incorporating a gamma distribution and logarithm-link function - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear-output regression ann lorann model  (LorAnn Oils Inc)
90
LorAnn Oils Inc linear-output regression ann lorann model
Rate of <t> anti-GP2 </t> antibody positivity in the UC, CD, and control groups
Linear Output Regression Ann Lorann Model, supplied by LorAnn Oils Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/linear+regression+models/linear+output+regression+ann+lorann+model/pmc02782432-57-6-9
Average 90 stars, based on 1 article reviews
linear-output regression ann lorann model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Rate of anti-GP2 antibody positivity in the UC, CD, and control groups

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Rate of anti-GP2 antibody positivity in the UC, CD, and control groups

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and the control group.

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and the control group.

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and UC

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and UC

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

ROC curve for GP2 and ASCA antibodies in Crohn’s disease and the control

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC curve for GP2 and ASCA antibodies in Crohn’s disease and the control

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

ROC curve for GP2 and ASCA antibodies in Crohn’s disease and ulcerative colitis patients

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC curve for GP2 and ASCA antibodies in Crohn’s disease and ulcerative colitis patients

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Combination of ASCA and anti-GP2 antibodies

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Combination of ASCA and anti-GP2 antibodies

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Rates of positivity for ASCA and anti-GP2 antibodies

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Rates of positivity for ASCA and anti-GP2 antibodies

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

Sensitivity, specificity, PPV, and NPV for anti-GP2 and ASCA in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Sensitivity, specificity, PPV, and NPV for anti-GP2 and ASCA in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Correlations between antibody positivity and disease behavior and area of involvement in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Correlations between antibody positivity and disease behavior and area of involvement in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Correlations between perianal involvement and antibody positivity in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Correlations between perianal involvement and antibody positivity in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Correlations between antibody positivity and surgical history in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Correlations between antibody positivity and surgical history in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: